July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™ device aims to leverage RFA to reduce reoperations and local recurrence in breast cancer treatment,” says Richard Stark, CEO of Innoblative Designs.
Committed to innovative surgical solutions